Pyxis Oncology (PYXS) Non Operating Income (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Non Operating Income data on file, last reported at $1.3 million in Q4 2025.

• On a quarterly basis, Non Operating Income fell 44.64% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $6.2 million, a 37.93% decrease from a year earlier, with the FY2025 full-year figure at $6.2 million, down 37.93% from the prior year.
• Non Operating Income for Q4 2025 stood at $1.3 million, down from $1.5 million in the prior quarter.
• Over the last five years, Non Operating Income for PYXS reached as high as $2.7 million in Q2 2024 and fell as low as -$2.6 million in Q3 2021.
• Historically, Non Operating Income has averaged $1.1 million across 5 years, with a median of $1.7 million in 2023.
• Across the five-year window, Non Operating Income sank 255500.0% in 2021 and surged 18911.11% in 2023, its largest moves.
• Year by year, Non Operating Income stood at -$403000.0 in 2021, then jumped by 564.52% to $1.9 million in 2022, then rose by 15.92% to $2.2 million in 2023, then climbed by 7.56% to $2.3 million in 2024, then plunged by 44.64% to $1.3 million in 2025.
• Per Business Quant data, the three most recent Non Operating Income figures were $1.3 million in Q4 2025, $1.5 million in Q3 2025, and $1.7 million in Q2 2025.